Literature DB >> 6957514

Determination of apolipoprotein B by kinetic (rate) nephelometry.

H Wieland, P Cremer, D Seidel.   

Abstract

Determination of apoB by rate nephelometry is a simple, rapid and precise method, which is also suitable for a routine laboratory. It can be standardized with lipoprotein-B or LDL fractions, but only if these fractions are diluted with fresh whole serum. The standardization is also valid for VLDL if the samples are diluted with hydroxypolyethoxydodecane (trade name: Thesit) in a concentration of 0.33 g/liter. Using rate nephelometry, a strong correlation between the contents of cholesterol and apoB of VLDL as well as of LDL can be demonstrated. Similar high correlations are achieved if apoB is determined chemically in isolated lipoprotein fractions. The ratio of apoB to cholesterol is constant but not the same in both VLDL and LDL. There is also a strong correlation between the concentration of apoB in whole serum with the LDL cholesterol values in a normotriglyceridemic population. Therefore, the assay of apoB in whole serum by rate nephelometry is proposed as a screening method for dyslipoproteinemia (increased concentrations of atherogenic lipoproteins at normal or elevated levels of cholesterol in plasma).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957514

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Incidence and mortality rates of myocardial infarction in Chinese workers aged 40-59 in relation to coronary risk factors. Results of a Chinese prospective study (Wuhan Study) in comparison to the Göttingen Risk Incidence and Prevalence Study (GRIPS).

Authors:  R Bernhardt; Z Feng; Y Deng; G Dai; P Cremer; G Stehle; D Seidel; G Schettler
Journal:  Klin Wochenschr       Date:  1991-03-18

2.  The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia.

Authors:  P Cremer; M Lakomek; W Beck; G Prindull
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.

Authors:  J Thiery; C Creutzfeldt; W Creutzfeldt; A K Walli; D Seidel
Journal:  Klin Wochenschr       Date:  1990-08-17

4.  Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia.

Authors:  P Schwandt; R Elsässer; C Schmidt; B Gertz; M Heil; J Augustin; K Seibel
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.